A scoring system to predict breast cancer mortality at 5 and 10 years

Abstract Although predictive models exist for mortality in breast cancer (BC) (generally all cause-mortality), they are not applicable to all patients and their statistical methodology is not the most powerful to develop a predictive model. Consequently, we developed a predictive model specific for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Esther Paredes-Aracil, Antonio Palazón-Bru, David Manuel Folgado-de la Rosa, José Ramón Ots-Gutiérrez, Antonio Fernando Compañ-Rosique, Vicente Francisco Gil-Guillén
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/df6ebec3af7049918d105efcac0cf965
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:df6ebec3af7049918d105efcac0cf965
record_format dspace
spelling oai:doaj.org-article:df6ebec3af7049918d105efcac0cf9652021-12-02T16:06:09ZA scoring system to predict breast cancer mortality at 5 and 10 years10.1038/s41598-017-00536-72045-2322https://doaj.org/article/df6ebec3af7049918d105efcac0cf9652017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00536-7https://doaj.org/toc/2045-2322Abstract Although predictive models exist for mortality in breast cancer (BC) (generally all cause-mortality), they are not applicable to all patients and their statistical methodology is not the most powerful to develop a predictive model. Consequently, we developed a predictive model specific for BC mortality at 5 and 10 years resolving the above issues. This cohort study included 287 patients diagnosed with BC in a Spanish region in 2003–2016. Main outcome variable: time-to-BC death. Secondary variables: age, personal history of breast surgery, personal history of any cancer/BC, premenopause, postmenopause, grade, estrogen receptor, progesterone receptor, c-erbB2, TNM stage, multicentricity/multifocality, diagnosis and treatment. A points system was constructed to predict BC mortality at 5 and 10 years. The model was internally validated by bootstrapping. The points system was integrated into a mobile application for Android. Mean follow-up was 8.6 ± 3.5 years and 55 patients died of BC. The points system included age, personal history of BC, grade, TNM stage and multicentricity. Validation was satisfactory, in both discrimination and calibration. In conclusion, we constructed and internally validated a scoring system for predicting BC mortality at 5 and 10 years. External validation studies are needed for its use in other geographical areas.Esther Paredes-AracilAntonio Palazón-BruDavid Manuel Folgado-de la RosaJosé Ramón Ots-GutiérrezAntonio Fernando Compañ-RosiqueVicente Francisco Gil-GuillénNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Esther Paredes-Aracil
Antonio Palazón-Bru
David Manuel Folgado-de la Rosa
José Ramón Ots-Gutiérrez
Antonio Fernando Compañ-Rosique
Vicente Francisco Gil-Guillén
A scoring system to predict breast cancer mortality at 5 and 10 years
description Abstract Although predictive models exist for mortality in breast cancer (BC) (generally all cause-mortality), they are not applicable to all patients and their statistical methodology is not the most powerful to develop a predictive model. Consequently, we developed a predictive model specific for BC mortality at 5 and 10 years resolving the above issues. This cohort study included 287 patients diagnosed with BC in a Spanish region in 2003–2016. Main outcome variable: time-to-BC death. Secondary variables: age, personal history of breast surgery, personal history of any cancer/BC, premenopause, postmenopause, grade, estrogen receptor, progesterone receptor, c-erbB2, TNM stage, multicentricity/multifocality, diagnosis and treatment. A points system was constructed to predict BC mortality at 5 and 10 years. The model was internally validated by bootstrapping. The points system was integrated into a mobile application for Android. Mean follow-up was 8.6 ± 3.5 years and 55 patients died of BC. The points system included age, personal history of BC, grade, TNM stage and multicentricity. Validation was satisfactory, in both discrimination and calibration. In conclusion, we constructed and internally validated a scoring system for predicting BC mortality at 5 and 10 years. External validation studies are needed for its use in other geographical areas.
format article
author Esther Paredes-Aracil
Antonio Palazón-Bru
David Manuel Folgado-de la Rosa
José Ramón Ots-Gutiérrez
Antonio Fernando Compañ-Rosique
Vicente Francisco Gil-Guillén
author_facet Esther Paredes-Aracil
Antonio Palazón-Bru
David Manuel Folgado-de la Rosa
José Ramón Ots-Gutiérrez
Antonio Fernando Compañ-Rosique
Vicente Francisco Gil-Guillén
author_sort Esther Paredes-Aracil
title A scoring system to predict breast cancer mortality at 5 and 10 years
title_short A scoring system to predict breast cancer mortality at 5 and 10 years
title_full A scoring system to predict breast cancer mortality at 5 and 10 years
title_fullStr A scoring system to predict breast cancer mortality at 5 and 10 years
title_full_unstemmed A scoring system to predict breast cancer mortality at 5 and 10 years
title_sort scoring system to predict breast cancer mortality at 5 and 10 years
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/df6ebec3af7049918d105efcac0cf965
work_keys_str_mv AT estherparedesaracil ascoringsystemtopredictbreastcancermortalityat5and10years
AT antoniopalazonbru ascoringsystemtopredictbreastcancermortalityat5and10years
AT davidmanuelfolgadodelarosa ascoringsystemtopredictbreastcancermortalityat5and10years
AT joseramonotsgutierrez ascoringsystemtopredictbreastcancermortalityat5and10years
AT antoniofernandocompanrosique ascoringsystemtopredictbreastcancermortalityat5and10years
AT vicentefranciscogilguillen ascoringsystemtopredictbreastcancermortalityat5and10years
AT estherparedesaracil scoringsystemtopredictbreastcancermortalityat5and10years
AT antoniopalazonbru scoringsystemtopredictbreastcancermortalityat5and10years
AT davidmanuelfolgadodelarosa scoringsystemtopredictbreastcancermortalityat5and10years
AT joseramonotsgutierrez scoringsystemtopredictbreastcancermortalityat5and10years
AT antoniofernandocompanrosique scoringsystemtopredictbreastcancermortalityat5and10years
AT vicentefranciscogilguillen scoringsystemtopredictbreastcancermortalityat5and10years
_version_ 1718385120137707520